BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced the appointment of Chief Commercial Officer (CCO), North America, Weston Fox to its Management Team. Mr. Fox, who has extensive experience and networks in Healthcare and Life Science, will work closely with the company’s established commercial team, to lead the business [...]

Comprehensive neurovascular unit model emulates features of the human brain and blood-brain barrier BOSTON, Mass. - Emulate, Inc., a leading provider of advanced in vitro models, today unveiled the Emulate Brain-Chip, which is designed for neuroscience researchers investigating neuroinflammatory disease and for drug developers seeking to improve drug discovery for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The comprehensive model incorporates cells from the human brain, including the [...]

New instrument overcomes cryo-EM barriers, implements artificial intelligence to deliver unparalleled ease-of-use at an affordable price HILLSBORO, Ore. -- Thermo Fisher Scientific, the world leader in serving science, today announced the new Thermo Scientific Tundra Cryo Transmission Electron Microscope (Cryo-TEM), a groundbreaking instrument that extends cryo-electron microscopy (cryo-EM) to more scientists by delivering industry-leading ease of [...]

Today, LGC announced the acquisition of Safefood 360°, the leading food safety and supplier management solutions platform. The acquisition expands LGC’s supply chain assurance offering which includes BRCGS’ leading certification scheme, Informed Sport and Informed Choice nutritional supplement endorsement marks and AXIO Proficiency Testing. Safefood 360° supports compliance with major food safety and supplier management requirements [...]

License for the use of the Affimer platform for affinity purification applications Cambridge and Wetherby, UK: Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a license agreement with Astrea Bioseparations (“Astrea”) for the use of the [...]

GMP-scale system enables advanced purification of peptides, oligos, RNA, and dsDNA based therapies and vaccines on a continuous basis. Allentown, PA -- A state-of-the-art lab, with a focus on developing continuous purification technologies, that was inaugurated in November 2019 will be home to the first-of-a-kind continuous HPLC. Named "Kyoto Works," the 2,600m2 facility is owned by YMC [...]

MENLO PARK, Calif. and CAMBRIDGE, United Kingdom -- Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing agreement between Astrea Bioseparations, a leader in affinity chromatography and bioseparations, and Avacta, a developer of innovative cancer therapies and diagnostics based on proprietary Affimer® and preCISION™ platforms. The licensing agreement gives Astrea access [...]

WASHINGTON -- Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danaher's science and technology strategy across the organization, including facilitating innovation and further development of scientific and technology talent. With [...]

All Good Things Come in Threes: KNAUER supports the Berlin City Mission's help for the homeless, the Plan International children's charity and the UN Refugee Aid It's uncomfortable outside, dark and winter! While many of us are sitting well sheltered in the warm, many homeless, sick and displaced people are having a really hard time. [...]

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has signed up the first collaborator in its recently announced Early Access Program for its prototype whole transcriptome panel. The Early Access Program is intended to allow select customers access [...]